Mechanism of action of the sesquiterpene compound helenalin in rhabdomyosarcoma cells
Rhabdomyosarcoma (RMS) is the most frequent soft tissue sarcoma in paediatric patients. Relapsed or refractory RMS shows very low 5-year survival rates, which urgently necessitates new chemotherapy agents. Herein, the sesquiterpene lactone, helenalin, was investigated as a new potential therapeutic...
Huvudupphovsmän: | Mun, H, Townley, HE |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
MDPI
2021
|
Liknande verk
Liknande verk
-
Mechanism of Action of the Sesquiterpene Compound Helenalin in Rhabdomyosarcoma Cells
av: Hakmin Mun, et al.
Publicerad: (2021-12-01) -
CD44 and CD221 directed magnetic cubosomes for the targeted delivery of helenalin to rhabdomyosarcoma cells
av: Mun, H, et al.
Publicerad: (2022) -
Active targeting of rhabdomyosarcoma cells using helenalin-loaded functionalised cubosomes
av: Mun, HM
Publicerad: (2023) -
NF-κB p65 repression by the sesquiterpene lactone, Helenalin, contributes to the induction of autophagy cell death
av: Feng, XiaoLing, et al.
Publicerad: (2013) -
NF-κB p65 repression by the sesquiterpene lactone, Helenalin, contributes to the induction of autophagy cell death
av: Lim Chuan, et al.
Publicerad: (2012-07-01)